1
|
Ryo E, Yatsuki K, Kamata H, Matsuki M. Gross movement counting of fetuses conceived with assisted reproductive technology using a fetal movement acceleration measurement recorder. Sci Rep 2024; 14:23539. [PMID: 39384755 PMCID: PMC11464511 DOI: 10.1038/s41598-024-70279-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2023] [Accepted: 08/14/2024] [Indexed: 10/11/2024] Open
Abstract
To investigate whether assisted reproductive technology (ART) affects gross fetal movement. A prospective cohort study. 65 women who conceived with ART (ART group) and 211 women (control group) without ART recorded fetal movement with the fetal movement acceleration measurement recorder at night weekly after 28 weeks. The number ratio of 10 s epochs with fetal movement to all epochs was calculated as the fetal movement parameter. When no fetal movement was observed for more than 5 min, it was defined as a no fetal movement period, and the average number per hour, the average duration, and the longest duration of the no fetal movement periods were calculated as the no fetal movement parameters. Gestational weeks were classified into 28-33 and 34-39 weeks, and the fetal movement parameter and the no fetal movement parameters were compared using the Student's t-test. The fetal movement parameters at 28-33 weeks were 17.43% (ART) and 16.58% (control) (p = 0.219), and those at 34-39 weeks were 11.72% (ART) and 11.96% (control) (p = 0.590). In the same way, for the no fetal movement parameters, the average numbers were 1.58 and 1.63 per hour (p = 0.357), and 2.36 and 2.30 per hour (p = 0.503). The average durations were 8.30 and 8.46 min (p = 0.712), and 9.20 and 9.51 min (p = 0.188). The longest durations were 16.26 and 17.02 min (p = 0.295), and 22.34 and 22.87 min (p = 0.534). ART does not affect gross fetal movement count.
Collapse
Affiliation(s)
- Eiji Ryo
- Department of Obstetrics and Gynecology, School of Medicine, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8606, Japan.
| | - Keita Yatsuki
- Department of Obstetrics and Gynecology, School of Medicine, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8606, Japan
| | - Hideo Kamata
- Department of Obstetrics and Gynecology, School of Medicine, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8606, Japan
| | - Miki Matsuki
- Department of Obstetrics and Gynecology, School of Medicine, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8606, Japan
| |
Collapse
|
2
|
Kato K, Kuroda T, Yamadera-Egawa R, Ezoe K, Aoyama N, Usami A, Miki T, Yamamoto T, Takeshita T. Preimplantation Genetic Testing for Aneuploidy for Recurrent Pregnancy Loss and Recurrent Implantation Failure in Minimal Ovarian Stimulation Cycle for Women Aged 35-42 Years: Live Birth Rate, Developmental Follow-up of Children, and Embryo Ranking. Reprod Sci 2023; 30:974-983. [PMID: 36085548 DOI: 10.1007/s43032-022-01073-z] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2022] [Accepted: 08/23/2022] [Indexed: 10/14/2022]
Abstract
This study was aimed at exploring the benefits of preimplantation genetic testing for aneuploidy (PGT-A) in ensuring a successful pregnancy in patients with recurrent pregnancy loss (RPL) caused by an abnormal number of chromosomes in the embryo and recurrent implantation failure (RIF). Thirty-two patients who underwent PGT-A (18 in the RIF protocol and 14 in the RPL protocol) were enrolled in the study, and 2556 patients who did not undergo PGT-A during the same in vitro fertilization (IVF) treatment period were enrolled as controls. All patients underwent minimal stimulation cycle IVF. In the RPL protocol, the live birth rate per embryo transfer (ET) and that per patient were higher with PGT-A (80.0% each) than without it (0% each; P = 0.0050), and the rate of miscarriages was lower with PGT-A than without it (20.0% vs. 100.0%, P = 0.0098). In the RIF protocol, there were no significant differences in the live birth rate per ET and in the rate of miscarriages between groups with and without PGT-A-90.0% vs. 69.2% (P = 0.2313) and 0% vs. 10.0% (P = 0.3297), respectively. None of the children whose mothers underwent PGT-A presented adverse findings at a 1.5-year developmental check-up. In conclusion, PGT-A in RPL is advantageous for improving the live birth rate per ET and that per patient in minimal stimulation cycle IVF; it reduces the rate of miscarriages. In addition, PGT-A might be more beneficial for embryo selection than the existing morphological grades of blastocysts, resulting in earlier conception.
Collapse
Affiliation(s)
- Keiichi Kato
- Kato Ladies Clinic, 7-20-3 Nishishinjyuku, Shinjyuku-ku, 160-0023, Tokyo, Japan.
| | - Tomoko Kuroda
- Kato Ladies Clinic, 7-20-3 Nishishinjyuku, Shinjyuku-ku, 160-0023, Tokyo, Japan
| | - Rie Yamadera-Egawa
- Kato Ladies Clinic, 7-20-3 Nishishinjyuku, Shinjyuku-ku, 160-0023, Tokyo, Japan
| | - Kenji Ezoe
- Kato Ladies Clinic, 7-20-3 Nishishinjyuku, Shinjyuku-ku, 160-0023, Tokyo, Japan
| | - Naoki Aoyama
- Kato Ladies Clinic, 7-20-3 Nishishinjyuku, Shinjyuku-ku, 160-0023, Tokyo, Japan
| | - Akemi Usami
- Kato Ladies Clinic, 7-20-3 Nishishinjyuku, Shinjyuku-ku, 160-0023, Tokyo, Japan
| | - Tetsuya Miki
- Kato Ladies Clinic, 7-20-3 Nishishinjyuku, Shinjyuku-ku, 160-0023, Tokyo, Japan
| | - Toshiyuki Yamamoto
- Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, 162-0054, Japan
| | - Toshiyuki Takeshita
- Department of Obstetrics and Gynaecology, Nippon Medical School, Tokyo, 113-8603, Japan
| |
Collapse
|
3
|
Aoki S, Hashimoto K, Ogawa K, Horikawa R, Sago H. Developmental outcomes in Japanese preschool‐age children conceived through assisted reproductive technology. J Obstet Gynaecol Res 2022; 48:2847-2852. [DOI: 10.1111/jog.15386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2022] [Revised: 07/07/2022] [Accepted: 07/22/2022] [Indexed: 11/28/2022]
Affiliation(s)
- Sayaka Aoki
- Research Center for Advanced Science and Technology The University of Tokyo Tokyo Japan
| | - Keiji Hashimoto
- Department of Rehabilitation Medicine Showa University School of Medicine Yokohama Japan
- Division of Endocrinology and Metabolism National Center for Child Health and Development Tokyo Japan
| | - Kohei Ogawa
- Center for Maternal‐Fetal, Neonatal and Reproductive Medicine National Center for Child Health and Development Tokyo Japan
| | - Reiko Horikawa
- Division of Endocrinology and Metabolism National Center for Child Health and Development Tokyo Japan
| | - Haruhiko Sago
- Center for Maternal‐Fetal, Neonatal and Reproductive Medicine National Center for Child Health and Development Tokyo Japan
| |
Collapse
|
4
|
Noda A, Ishikuro M, Obara T, Murakami K, Ueno F, Matsuzaki F, Onuma T, Watanabe Z, Shiga N, Iwama N, Hirotaka H, Otsuka T, Tachibana M, Tomita H, Saito M, Sugawara J, Kure S, Yaegashi N, Kuriyama S. Association between maternal infertility treatment and child neurodevelopment: findings from the Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study in Miyagi and Iwate Prefectures, Japan. BMJ Open 2022; 12:e060944. [PMID: 35672073 PMCID: PMC9174802 DOI: 10.1136/bmjopen-2022-060944] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
OBJECTIVES This study aimed to examine the association between infertility treatment and neurodevelopment in children at 2 and 3.5 years of age. DESIGN Prospective cohort study. SETTING AND PARTICIPANTS The study population consisted of mother-child pairs who participated in the Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study in Miyagi and Iwate Prefectures, Japan. Pregnant women were recruited in obstetric clinics or hospitals and their children were followed up by the questionnaire. OUTCOME MEASURES The children's neurodevelopmental outcomes were assessed at 2 and 3.5 years of age using the Ages and Stages Questionnaire, third edition (ASQ-3), which consists of questions on five developmental domains. We performed a multivariate logistic regression analysis of the association between infertility treatment (including ovulation induction (OI), artificial insemination with husband's sperm (AIH) and assisted reproductive technology (ART)) and the clinical range of ASQ-3. RESULTS Of 9655 mother-child pairs, 273 (2.8%) and 487 (5.0%) were conceived through OI/AIH and ART, respectively. The odds of having developmental delays at 2 years of age were higher in children conceived through OI/AIH (OR, 1.36; 95% CI 1.00 to 1.85) and ART (OR, 1.36; 95% CI 1.07 to 1.72) than in those conceived naturally. Additionally, OI/AIH and ART were significantly associated with communication (OR, 1.93; 95% CI 1.25 to 2.98) and gross motor (OR, 1.50; 95% CI 1.08 to 2.09) delays, respectively. There were no statistically significant differences in the odds of having developmental delays at 3.5 years of age in children conceived through OI/AIH (OR, 1.13; 95% CI 0.79 to 1.61) and ART (OR, 1.03; 95% CI 0.78 to 1.37). CONCLUSION In this study, we found a significant association between infertility treatment and children's neurodevelopment at 2 years of age, whereas no statistically significant differences were found at 3.5 years of age.
Collapse
Affiliation(s)
- Aoi Noda
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan
- Division of Molecular Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
- Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Miyagi, Japan
| | - Mami Ishikuro
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan
- Division of Molecular Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
| | - Taku Obara
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan
- Division of Molecular Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
- Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Miyagi, Japan
| | - Keiko Murakami
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan
- Division of Molecular Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
| | - Fumihiko Ueno
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan
- Division of Molecular Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
| | - Fumiko Matsuzaki
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan
- Division of Molecular Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
| | - Tomomi Onuma
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan
- Division of Molecular Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
| | - Zen Watanabe
- Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Miyagi, Japan
- Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
| | - Naomi Shiga
- Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Miyagi, Japan
- Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
| | - Noriyuki Iwama
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan
- Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Miyagi, Japan
- Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
| | - Hamada Hirotaka
- Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Miyagi, Japan
- Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
| | - Tatsui Otsuka
- Department of Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
- Department of Psychiatry, Tohoku University Hospital, Sendai, Miyagi, Japan
| | - Masahito Tachibana
- Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Miyagi, Japan
- Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
| | - Hiroaki Tomita
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan
- Department of Psychiatry, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
- Department of Psychiatry, Tohoku University Hospital, Sendai, Miyagi, Japan
- Department of Disaster Psychiatry, International Research Institute of Disaster Science, Tohoku University, Sendai, Miyagi, Japan
| | - Masatoshi Saito
- Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Miyagi, Japan
- Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
- Department of Maternal and Fetal Therapeutics, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
| | - Junichi Sugawara
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan
- Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Miyagi, Japan
- Environment and Genome Research Center, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
| | - Shigeo Kure
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan
- Department of Pediatrics, Tohoku University School of Medicine, Sendai, Miyagi, Japan
| | - Nobuo Yaegashi
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan
- Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Miyagi, Japan
- Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
- Environment and Genome Research Center, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
| | - Shinichi Kuriyama
- Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan
- Division of Molecular Epidemiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan
- International Research Institute of Disaster Science, Tohoku University, Sendai, Miyagi, Japan
| |
Collapse
|
5
|
Verhaeghe C, Marchand-Martin L, Kaminski M, Gascoin G, Foix L'hélias L, Ancel PY, Bouet PE, Morgan AS. Neurodevelopment at 5 years of age for preterm-born children according to mode of conception: a cohort study. Am J Obstet Gynecol 2022; 227:606.e1-606.e21. [PMID: 35671779 DOI: 10.1016/j.ajog.2022.05.062] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2022] [Revised: 05/20/2022] [Accepted: 05/28/2022] [Indexed: 11/01/2022]
Abstract
BACKGROUND Preterm delivery is a risk factor for sub-optimal neurodevelopment. Pregnancies conceived after medically-assisted reproduction - which includes in vitro fertilisation, with or without intracytoplasmic insemination, as well as induction of ovulation followed by intra-uterine insemination or timed intercourse - have a higher risk of preterm delivery. Few studies have evaluated the outcome at more than 2 years of age of such preterm-born children. OBJECTIVE To evaluate neurodevelopmental outcome at 5 ½ years of age of children born preterm according to the mode of conception (spontaneous versus medically-assisted reproduction). STUDY DESIGN 4349 children born between 24 and 34 weeks of gestation who survived to 5 ½ years of age in the 2011 French prospective national cohort study EPIPAGE-2 were included: 814 in the medically-assisted reproduction group (433 by in vitro fertilisation, with or without intracytoplasmic insemination, and 381 by induction of ovulation) and 3535 in the spontaneously conceived group. Neurodevelopmental outcomes studied were sensory (hearing and vision) impairments, cerebral palsy, cognition and developmental coordination disorders. Multivariate analyses were performed with generalised estimating equation models adjusted for gestational age, antenatal steroids and social characteristics. All analyses were performed following multiple imputation. Sensitivity analyses were performed with the populations of singletons and cases with complete data. RESULTS No differences in cerebral palsy (adjusted odds ratio =1.00, 95% confidence interval 0.67-1.49), neurodevelopmental impairment (adjusted odds ratio=1.09; 95% confidence interval 0.82-1.45), or developmental coordination disorders (adjusted odds ratio=0.75; 95% confidence interval 0.50-1.12) were found between children born following medically-assisted reproduction and children born following spontaneous conception after adjustment for sociodemographic factors. For proportions of children with an intelligence quotient below one and two standard deviations, there were no differences between those born after medically-assisted reproduction or spontaneous pregnancy (respectively, adjusted odds ratio= 0.99 95% confidence interval 0.80-1.23, and adjusted odds ratio=1.14; 95% confidence interval 0.83-1.56). In subgroup analyses, no differences were seen between children born following induction of ovulation nor among those conceived through in vitro fertilisation when compared to children conceived spontaneously. Sensitivity analyses were consistent with the main results. CONCLUSION In this cohort of preterm born children, there was no evidence of an impact of the mode of conception on neurodevelopmental outcomes at 5 ½ years of age.
Collapse
Affiliation(s)
- Caroline Verhaeghe
- Université Paris Cité, Centre of Research in Epidemiology and StatisticS (CRESS), Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), INSERM, INRAE, F-75006, Paris, France; Service de gynécologie-obstétrique, CHU d'Angers, 4, rue Larrey, 49033 Angers, France
| | - Laetitia Marchand-Martin
- Université Paris Cité, Centre of Research in Epidemiology and StatisticS (CRESS), Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), INSERM, INRAE, F-75006, Paris, France
| | - Monique Kaminski
- Université Paris Cité, Centre of Research in Epidemiology and StatisticS (CRESS), Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), INSERM, INRAE, F-75006, Paris, France
| | - Géraldine Gascoin
- Department of Neonatology, Hôpital des Enfants, CHU Toulouse, 31059 Toulouse, France
| | - Laurence Foix L'hélias
- Université Paris Cité, Centre of Research in Epidemiology and StatisticS (CRESS), Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), INSERM, INRAE, F-75006, Paris, France; Sorbonne University, Paris, France; Department of Neonatal Pediatrics, Trousseau Hospital, Assistance Publique - Hôpitaux de Paris, 75012 Paris, France
| | - Pierre-Yves Ancel
- Université Paris Cité, Centre of Research in Epidemiology and StatisticS (CRESS), Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), INSERM, INRAE, F-75006, Paris, France; Clinical Investigation Center P1419, Assistance Publique - Hôpitaux de Paris, Paris, France
| | - Pierre-Emmanuel Bouet
- Service de gynécologie-obstétrique, CHU d'Angers, 4, rue Larrey, 49033 Angers, France
| | - Andrei S Morgan
- Université Paris Cité, Centre of Research in Epidemiology and StatisticS (CRESS), Obstetrical Perinatal and Pediatric Epidemiology Research Team (EPOPé), INSERM, INRAE, F-75006, Paris, France; Elizabeth Garrett Anderson Institute for Women's Health London, University College London, London, UK; Department of Neonatalogy, Port-Royal Hospital, Assistance Publique - Hôpitaux de Paris, 75014 Paris, France.
| |
Collapse
|
6
|
Ohno M, Tanaka A, Nagayoshi M, Yamaguchi T, Takemoto Y, Tanaka I, Watanabe S, Itakura A. Modified permeable cryoprotectant-free vitrification method for three or fewer ejaculated spermatozoa from cryptozoospermic men and 7-year follow-up study of 14 children born from this method. Hum Reprod 2021; 35:1019-1028. [PMID: 32383453 DOI: 10.1093/humrep/deaa072] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2019] [Revised: 01/25/2020] [Accepted: 03/17/2020] [Indexed: 11/14/2022] Open
Abstract
STUDY QUESTION What technique can be used to successfully cryopreserve three or fewer ejaculated spermatozoa from cryptozoospermic men and is the physical and cognitive development of children born after this technique normal? SUMMARY ANSWER The modified cryopreservation method for three or fewer human spermatozoa from cryptozoospermic men showed a recovery rate above 95% and a survival rate just under 90%, and the physical and cognitive abilities of the children born after ICSI were comparable to those born after natural conception. WHAT IS KNOWN ALREADY Clinical outcomes of ICSI using cryptozoospermic men's ejaculated spermatozoa are considered to be inferior to that using testicular spermatozoa from microsurgical testicular sperm extraction (Micro-TESE), possibly because the DNA fragmentation rate is higher in ejaculated spermatozoa than in testicular spermatozoa from Micro-TESE. STUDY DESIGN, SIZE, DURATION Evaluation of the efficiency of cryopreservation of three or fewer spermatozoa was conducted retrospectively at St. Mother Clinic. The physical and cognitive development of children born after this method was studied between 2011 and 2018. PARTICIPANTS/MATERIALS, SETTING, METHODS This study included 28 cryptozoospermic men who had three or fewer morphologically normal and motile spermatozoa in their ejaculate after centrifugation and who preferred using cryopreserved spermatozoa to Micro-TESE. Control subjects were 31 cryptozoospermic patients using fresh spermatozoa from their ejaculates and 20 non-obstructive azoospermic patients with fewer than 10 spermatozoa obtained by TESE and vitrified. Clinical outcomes among three groups, vitrified spermatozoa from the ejaculate, fresh spermatozoa from the ejaculate and vitrified spermatozoa from the testis, were statistically analysed. For the 7-year follow up study of the 14 children born after ICSI using the ejaculated vitrified spermatozoa, the Japanese government-issued Boshi Kenko Techo (Mother-Child Handbook) and Kinder Infant Development Scale (KIDS scale) were used to determine whether their physical and cognitive development was comparable to that of naturally conceived children. MAIN RESULTS AND THE ROLE OF CHANCE Recovery and survival rates were 97.8% (510/521) and 87.1% (444/510) for vitrified spermatozoa from the ejaculate and 92.7% (152/164) and 60.5% (92/152) for vitrified spermatozoa from the testis. Clinical pregnancies (%), miscarriages (%) and live birth rates (%), respectively, among the three groups were as follows: vitrified spermatozoa from the ejaculate: 15(25.0), 2(13.3), 13(21.7); fresh spermatozoa from the ejaculate: 26(24.3), 5(19.2), 20(18.7); and vitrified spermatozoa from the testis: 3(16.7), 0(0.0), 3(16.7). Among the groups, there were no statistically significant differences except for the sperm survival rate and the oocyte fertilisation rate, which were lower for vitrified spermatozoa from the testis compared with vitrified spermatozoa from the ejaculate. The 7-year follow-up study showed that the physical and cognitive development of 14 children born after ICSI using vitrified ejaculated spermatozoa from the ejaculate was comparable to that of naturally conceived children. LIMITATIONS, REASONS FOR CAUTIONS The maximum number of spermatozoa to which this method can be applied successfully is about 10. When the number of aspirated spermatozoa is over 10, some of them change direction after colliding with each other inside the aspiration pipette and reach the mineral oil, and once this happens, they cannot be expelled out of the pipette. Even though we did not find evidence of DNA fragmentation, further studies with larger participant numbers and longer time periods are necessary. WIDER IMPLICATIONS OF THE FINDINGS This technique is very useful for the cryopreservation of very small numbers of testicular spermatozoa (fewer than 10) in order to avoid or reduce Micro-TESE interventions. STUDY FUNDING/COMPETING INTEREST(S) No external funding was received to undertake this study. There are no competing interests. TRIAL REGISTRATION NUMBER N/A.
Collapse
Affiliation(s)
- Motoharu Ohno
- Department of Obstetrics and Gynecology, Saint Mother Obstetrics and Gynecology Clinic and Institute for ART, Fukuoka, Japan.,Department of Obstetrics and Gynecology, Juntendo University School of Medicine, Tokyo, Japan
| | - Atsushi Tanaka
- Department of Obstetrics and Gynecology, Saint Mother Obstetrics and Gynecology Clinic and Institute for ART, Fukuoka, Japan
| | - Motoi Nagayoshi
- Department of Obstetrics and Gynecology, Saint Mother Obstetrics and Gynecology Clinic and Institute for ART, Fukuoka, Japan
| | - Takashi Yamaguchi
- Department of Obstetrics and Gynecology, Saint Mother Obstetrics and Gynecology Clinic and Institute for ART, Fukuoka, Japan
| | - Youichi Takemoto
- Department of Obstetrics and Gynecology, Saint Mother Obstetrics and Gynecology Clinic and Institute for ART, Fukuoka, Japan
| | - Izumi Tanaka
- Department of Obstetrics and Gynecology, Saint Mother Obstetrics and Gynecology Clinic and Institute for ART, Fukuoka, Japan
| | - Seiji Watanabe
- Department of Anatomical Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| | - Atsuo Itakura
- Department of Obstetrics and Gynecology, Juntendo University School of Medicine, Tokyo, Japan
| |
Collapse
|
7
|
Maeda Y, Ogawa K, Morisaki N, Tachibana Y, Horikawa R, Sago H. Association between perinatal anemia and postpartum depression: A prospective cohort study of Japanese women. Int J Gynaecol Obstet 2019; 148:48-52. [DOI: 10.1002/ijgo.12982] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2019] [Revised: 07/24/2019] [Accepted: 09/24/2019] [Indexed: 11/06/2022]
Affiliation(s)
- Yuto Maeda
- Center for Maternal‐Fetal, Neonatal and Reproductive MedicineNational Center for Child Health and Development Tokyo Japan
| | - Kohei Ogawa
- Center for Maternal‐Fetal, Neonatal and Reproductive MedicineNational Center for Child Health and Development Tokyo Japan
- Department of Social MedicineNational Research Institute for Child Health and Development Tokyo Japan
| | - Naho Morisaki
- Department of Social MedicineNational Research Institute for Child Health and Development Tokyo Japan
| | - Yoshiyuki Tachibana
- Department of PsychiatryNational Center for Child Health and Development Tokyo Japan
| | - Reiko Horikawa
- Division of Endocrinology and MetabolismNational Center for Child Health and Development Tokyo Japan
| | - Haruhiko Sago
- Center for Maternal‐Fetal, Neonatal and Reproductive MedicineNational Center for Child Health and Development Tokyo Japan
| |
Collapse
|
8
|
Tanaka A, Suzuki K, Nagayoshi M, Tanaka A, Takemoto Y, Watanabe S, Takeda S, Irahara M, Kuji N, Yamagata Z, Yanagimachi R. Ninety babies born after round spermatid injection into oocytes: survey of their development from fertilization to 2 years of age. Fertil Steril 2019; 110:443-451. [PMID: 30098696 DOI: 10.1016/j.fertnstert.2018.04.033] [Citation(s) in RCA: 44] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2017] [Revised: 04/09/2018] [Accepted: 04/24/2018] [Indexed: 11/24/2022]
Abstract
OBJECTIVE To compare physical and cognitive development of babies born after round spermatid injection (ROSI) with those born after natural conception. DESIGN Comparison of efficiencies of ROSI and ICSI using testicular spermatozoa, performed in the St. Mother Clinic. Physical and cognitive development of ROSI babies recorded by parents in the government-issued Mother-Child Handbook was checked and verified by attending pediatricians. Data included baby's weight gain and response to parents' voice/gesture. SETTING Assisted reproduction technology practice. PATIENT(S) A total of 721 men participated in ROSI; 90 ROSI babies were followed for 2 years for their physical and cognitive development. Control subjects were 1,818 naturally born babies. INTERVENTION(S) Surgical retrieval of spermatogenic cells from testes; selection and injection of round spermatids into oocytes; oocyte activation, in vitro culture of fertilized eggs, and embryo transfer to mothers. MAIN OUTCOME MEASURE(S) Physical and cognitive development of ROSI babies (e.g., body weight increase, response to parents, and understanding and speaking simple language) compared with naturally born babies. RESULT(S) Of 90 ROSI babies, three had congenital aberrations at birth, which corrected spontaneously (ventricular septa) or after surgery (cleft lip and omphalocele). Physical and cognitive development of ROSI babies was similar to those of naturally born babies. CONCLUSION(S) There were no significant differences between ROSI and naturally conceived babies in either physical or cognitive development during the first 2 years after birth. CLINICAL TRIAL REGISTRATION NUMBER UMIN Clinical Trials Registry UMIN000006117.
Collapse
Affiliation(s)
- Atsushi Tanaka
- Saint Mother Obstetrics and Gynecology Clinic and Institute for Assisted Reproductive Technologies, Fukuoka, Japan.
| | - Kohta Suzuki
- Department of Health and Psychosocial Medicine, Aichi Medical University School of Medicine, Aichi, Japan
| | - Motoi Nagayoshi
- Saint Mother Obstetrics and Gynecology Clinic and Institute for Assisted Reproductive Technologies, Fukuoka, Japan
| | - Akihiro Tanaka
- Saint Mother Obstetrics and Gynecology Clinic and Institute for Assisted Reproductive Technologies, Fukuoka, Japan
| | - Youichi Takemoto
- Saint Mother Obstetrics and Gynecology Clinic and Institute for Assisted Reproductive Technologies, Fukuoka, Japan
| | - Seiji Watanabe
- Department of Anatomic Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
| | - Satoru Takeda
- Department of Obstetrics and Gynecology, Juntendo University School of Medicine, Tokyo, Japan
| | - Minoru Irahara
- Department of Obstetrics and Gynecology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
| | - Naoaki Kuji
- Department of Obstetrics and Gynecology, Tokyo Medical College, Tokyo, Japan
| | - Zentaro Yamagata
- Basic Science for Clinical Medicine, Division of Medicine, Graduate School Department of Interdisciplinary Research, University of Yamanashi, Yamanashi, Japan
| | | |
Collapse
|
9
|
Molines L, Nusinovici S, Moreau M, Remy M, May-Panloup P, Flamant C, Roze JC, Van Bogaert P, Bouet PE, Gascoin G. Impact of mode of conception on neonatal and neurodevelopmental outcomes in preterm infants. Hum Reprod 2018; 34:356-364. [DOI: 10.1093/humrep/dey345] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2018] [Accepted: 11/04/2018] [Indexed: 11/14/2022] Open
Affiliation(s)
- Lisa Molines
- Department of Neonatal Medicine, Angers University Hospital, Angers, France
| | - Simon Nusinovici
- INSERM CIC 1413, Clinical Investigation Center, Nantes University Hospital, Nantes, France
- Loire Infant Follow-up Team (LIFT) Network, Pays de Loire, France
| | - Marie Moreau
- Department of Neonatal Medicine, Angers University Hospital, Angers, France
| | - Mathilde Remy
- Department of Neonatal Medicine, Angers University Hospital, Angers, France
| | - Pascale May-Panloup
- Department of Reproductive Biology, Angers University Hospital, Angers, France
| | - Cyril Flamant
- Loire Infant Follow-up Team (LIFT) Network, Pays de Loire, France
- Department of Neonatal Medicine, Nantes University Hospital, Nantes, France
| | - Jean-Christophe Roze
- Loire Infant Follow-up Team (LIFT) Network, Pays de Loire, France
- Department of Neonatal Medicine, Nantes University Hospital, Nantes, France
| | - Patrick Van Bogaert
- Loire Infant Follow-up Team (LIFT) Network, Pays de Loire, France
- Department of Paediatric Neurology, Angers University Hospital, Angers, France
| | | | - Géraldine Gascoin
- Department of Neonatal Medicine, Angers University Hospital, Angers, France
- Loire Infant Follow-up Team (LIFT) Network, Pays de Loire, France
| |
Collapse
|
10
|
Ogawa K, Morisaki N, Sago H, Fujiwara T, Horikawa R. Association between women's perceived ideal gestational weight gain during pregnancy and pregnancy outcomes. Sci Rep 2018; 8:11574. [PMID: 30069014 PMCID: PMC6070475 DOI: 10.1038/s41598-018-29936-z] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2018] [Accepted: 07/20/2018] [Indexed: 12/18/2022] Open
Abstract
We aimed to clarify which beliefs motivate women to control their weight during pregnancy and how such values influence pregnancy outcomes. Using a questionnaire administered during mid- to late- pregnancy in a hospital-based prospective cohort study, we explored women’s perceived ideal GWG and their reasons for having this ideal. Using multivariate regression, we evaluated the association between women’s perceived ideal GWG and pregnancy outcomes. Among 1,691 normal and underweight women, the most common reason women thought avoiding excessive weight gain was important was “for ease of delivery and/or her health and well-being”. 912 (54%) women wished to maintain their GWG below 12 kg, the upper limit recommended by the Japanese governmental guidelines, and had a lower actual GWG compared to those who had less stringent notions of GWG. Compared to women whose perceived ideal GWG was 12 kg, those who considered their perceived limit to be lower had infants with lower birthweight on average despite no significant reduction in cesarean delivery rate or post-partum body weight retention. Our findings suggest that women who believe they should limit their weight gain to an amount lower than the upper limit of current guidelines succeeded in gaining significantly less weight but received no additional benefit.
Collapse
Affiliation(s)
- Kohei Ogawa
- Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.,Department of Social Medicine, National Center for Child Health and Development, Tokyo, Japan.,Collaborative Departments of Advanced Pediatric Medicine, Graduate School of Medicine, Tohoku University, Sendai, Japan
| | - Naho Morisaki
- Department of Social Medicine, National Center for Child Health and Development, Tokyo, Japan.
| | - Haruhiko Sago
- Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.,Collaborative Departments of Advanced Pediatric Medicine, Graduate School of Medicine, Tohoku University, Sendai, Japan
| | - Takeo Fujiwara
- Department of Global Health Promotion, Tokyo Medical and Dental University, Tokyo, Japan
| | - Reiko Horikawa
- Department of Endocrinology, National Center for Child Health and Development, Tokyo, Japan
| |
Collapse
|
11
|
Aoki S, Hashimoto K, Ogawa K, Horikawa R, Sago H. Developmental outcomes of Japanese children born through Assisted Reproductive Technology (ART) in toddlerhood. J Obstet Gynaecol Res 2018; 44:929-935. [DOI: 10.1111/jog.13613] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2017] [Accepted: 01/22/2018] [Indexed: 11/27/2022]
Affiliation(s)
- Sayaka Aoki
- Center for Health and Environmental Risk Research; National Institute for Environmental Studies, Tsukuba; Tokyo Japan
| | - Keiji Hashimoto
- Division of Rehabilitation Medicine and Developmental Evaluation Center; National Center for Child Health and Development; Tokyo Japan
| | - Kohei Ogawa
- Maternal-Fetal Neonatal Medicine; National Center for Child Health and Development; Tokyo Japan
| | - Reiko Horikawa
- Division of Endocrinology and Metabolism; National Center for Child Health and Development; Tokyo Japan
| | - Haruhiko Sago
- Maternal-Fetal Neonatal Medicine; National Center for Child Health and Development; Tokyo Japan
| |
Collapse
|
12
|
Ogawa K, Morisaki N, Kobayashi M, Jwa SC, Tani Y, Sago H, Horikawa R, Fujiwara T. Maternal vegetable intake in early pregnancy and wheeze in offspring at the age of 2 years. Eur J Clin Nutr 2018; 72:761-771. [PMID: 29434319 DOI: 10.1038/s41430-018-0102-5] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2017] [Revised: 09/24/2017] [Accepted: 11/29/2017] [Indexed: 12/14/2022]
Abstract
BACKGROUND/OBJECTIVES Vegetable intake during childhood may reduce the risk of subsequent asthma. We verified the effect of maternal intake during pregnancy on asthma risk in offspring, which has rarely been studied. SUBJECTS/METHODS In a hospital-based birth cohort study conducted in Tokyo, we administered a food frequency questionnaire at two periods during the respondents' pregnancy: early and mid to late periods. In addition, a questionnaire including the International Study of Asthma and Allergies in Childhood questionnaire was conducted when the offspring were 2 years old. Multivariate Poisson regression adjusting for maternal baseline demographics was used to elucidate the association between maternal vegetable intake and the incidence of wheeze in the offspring. RESULTS Among 310 singletons, 82 (26.5%) experienced wheeze at 2 years of age. Women with the highest intake of cruciferous, and folate-rich vegetables during early pregnancy reported a significantly lower prevalence of wheeze in their child at 2 years of age in comparison with those who reported the lowest intake (adjusted risk ratio: 0.48 and 0.47, 95% confidence interval: 0.26-0.89, and 0.25-0.87, respectively). In trend analysis, a higher maternal intake of cruciferous, folate-rich vegetables, and total vegetables during early pregnancy was less likely to be associated with wheeze in the offspring at 2 years old (p for trend: 0.038, <0.001, and 0.028, respectively). Maternal vegetable intake during mid to late pregnancy was not associated with wheeze in the offspring. CONCLUSIONS Maternal vegetable intake during early pregnancy may have a protective effect against asthma in offspring at 2 years of age.
Collapse
Affiliation(s)
- Kohei Ogawa
- Department of Social Medicine, National Research Institute for Child Health and Development, 2-10-1 Okura, Tokyo, 157-8535, Japan. .,Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Tokyo, 157-8535, Japan. .,Collaborative Departments of Advanced Pediatric Medicine, Graduate School of Medicine, Tohoku University, 2-1 Seiryotyo, aoba-ku, Sendaishi, 980-8575, Japan.
| | - Naho Morisaki
- Department of Social Medicine, National Research Institute for Child Health and Development, 2-10-1 Okura, Tokyo, 157-8535, Japan
| | - Minatsu Kobayashi
- Department of Food Science, Otsuma Women's University, 12 Sanbancho, Tokyo, 102-8537, Japan
| | - Seung Chik Jwa
- Department of Social Medicine, National Research Institute for Child Health and Development, 2-10-1 Okura, Tokyo, 157-8535, Japan
| | - Yukako Tani
- Department of Global Health Promotion, Tokyo Medical and Dental University, 1-5-45 Yushima, Tokyo, 113-8510, Japan.,Research Fellow of Japan Society for the Promotion of Science, 5-3-1, Kojimachi, Tokyo, Japan
| | - Haruhiko Sago
- Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Tokyo, 157-8535, Japan.,Collaborative Departments of Advanced Pediatric Medicine, Graduate School of Medicine, Tohoku University, 2-1 Seiryotyo, aoba-ku, Sendaishi, 980-8575, Japan
| | - Reiko Horikawa
- Division of Endocrinology and Metabolism, National Center for Child Health and Development, 2-10-1 Okura, Tokyo, 157-8535, Japan
| | - Takeo Fujiwara
- Department of Social Medicine, National Research Institute for Child Health and Development, 2-10-1 Okura, Tokyo, 157-8535, Japan.,Department of Global Health Promotion, Tokyo Medical and Dental University, 1-5-45 Yushima, Tokyo, 113-8510, Japan
| |
Collapse
|